Eli Lilly Just Got a Huge Vote of Confidence From Morgan Stanley -- and It's All About Mounjaro

Eli Lilly just reported strong results for a next-generation GLP-1 drug that it is developing.  GLP-1 developments in India aren't headline-grabbing news, but they are just as important to understand.